Deanol
OTHER NAME(S): 2-Dimethyl Aminoethanol, Acéglumate de Déanol, Acétamido-benzoate de Déanol, Benzilate de Déanol, Bisorcate de Déanol, Cyclohexylpropionate de Déanol, Deaner, Deanol Aceglumate, Deanol Acetamidobenzoate, Deanol Benzilate, Deanol Bisorcate, Deanol Cyclohexylpropionate, Deanol Hemisuccinate, Deanol Pidolate, Deanol Tartrate, Dimethylaminoethanol, Diméthylaminoéthanol, Dimethylaminoethanol Bitartrate, Dimethylethanolamine, DMAE, DMAE Bitartrate, Hémisuccinate de Déanol, Pidolate de Déanol, 2-Dimethylaminoethanol, 2-(Dimethylamino) ethanol, Déanol
Overview
Deanol is a chemical used to make choline. Choline is involved in reactions that form acetylcholine, a chemical in the brain and other areas of the body.
Having more choline in the body might increase the production of acetylcholine, which is involved in brain and nervous system function. This might have effects on some neurological conditions.
People use deanol for Alzheimer disease, a movement disorder called tardive dyskinesia, attention deficit-hyperactivity disorder (ADHD), autism, and many other conditions, but there is no good scientific evidence to support these uses.
Deanol was previously sold by Riker Laboratories as the prescription drug Deaner. It was prescribed for the management of children with behavior problems and learning difficulties. Deanol is not an approved food additive in the US, nor is it an orphan drug, as some marketing suggests.
Uses
Likely InEffective for
- Alzheimer disease. Taking deanol by mouth does not seem to improve memory in people with Alzheimer disease.
- A movement disorder often caused by antipsychotic drugs (tardive dyskinesia). Taking deanol by mouth does not seem to improve symptoms of tardive dyskinesia.
There is interest in using deanol for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful.
Side Effects
When taken by mouth: Deanol is possibly safe when used in doses up to 2 grams daily for up to 4 weeks or 500 mg daily for up to 3 months. It seems to be well tolerated. Side effects might include stomachcramps, stomach pain, diarrhea, drowsiness, nausea, and vomiting.
When applied to the skin: There isn't enough reliable information to know if deanol is safe or what the side effects might be.
Precautions
When taken by mouth: Deanol is possibly safe when used in doses up to 2 grams daily for up to 4 weeks or 500 mg daily for up to 3 months. It seems to be well tolerated. Side effects might include stomachcramps, stomach pain, diarrhea, drowsiness, nausea, and vomiting.
When applied to the skin: There isn't enough reliable information to know if deanol is safe or what the side effects might be.
Pregnancy and breast-feeding: There isn't enough reliable information to know if deanol is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.
Depression: Deanol might make depression worse.
Schizophrenia: Deanol might make schizophrenia symptoms worse.
Tonic-clonic seizures: Deanol should not be used by people with tonic-clonic seizure disorders. It might make seizures worse.
Interactions
Moderate Interaction
Be cautious with this combination
- Drying medications (Anticholinergic drugs) interacts with DeanolDeanol can increase a chemical in the body called acetylcholine. Acetylcholine plays a big part in many important body functions. Some medications, called anticholinergic drugs, block the effects of acetylcholine in the body. Taking deanol might decrease the effects of anticholinergic drugs.
- Various medications used for glaucoma, Alzheimer disease, and other conditions (Cholinergic drugs) interacts with DeanolDeanol can increase a chemical in the body called acetylcholine. Some medications that are used for glaucoma, Alzheimer disease, and other conditions, also increase acetylcholine levels. Taking deanol with these medications might increase the chance of side effects.
Dosing
There isn't enough reliable information to know what an appropriate dose of deanol might be. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult a healthcare professional before using.
References
- Martindale W. Martindale the Extra Pharmacopoeia. Pharmaceutical Press, 1999.
- Davies C, Maidment S, Hanley P, et al. Dimethylaminoethanol (DMAE). HSE. Risk assessment document; EH72/2;1997. (TOXLINE).
- Re O. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Curr Ther Res Clin Exp 1974;16:1238-42.
- Pieralisi G, Ripari P, Vecchiet L. Effects of a standardized ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals, and trace elements on physical performance during exercise. Clin Ther 1991;13:373-82.
- George J, Pridmore S, Aldous D. Double blind controlled trial of deanol in tardive dyskinesia. Aust N Z J Psychiatry 1981;15:68-71.
- Penovich P, Morgan JP, Kerzner B, et al. Double-blind evaluation of deanol in tardive dyskinesia. JAMA 1978;239:1997-8.
- de Montigny C, Chouinard G, Annable L. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study. Psychopharmacology (Berl) 1979;65:219-23.
- Lindeboom SF, Lakke JP. Deanol and physostigmine in the treatment of L-dopa-induced dyskinesias. Acta Neurol Scand 1978;58:134-8.
- Jus A, Villeneuve A, Gautier J, et al. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study. Neuropsychobiology 1978;4:140-9.
- Oettinger L Jr. Pediatric psychopharmacology. A review with special reference to deanol. Dis Nerv Syst 1977;38:25-31.
- Lewis JA, Young R. Deanol and methylphenidate in minimal brain dysfunction. Clin Pharmacol Ther 1975;17:534-40.
- Fisman M, Mersky H, Helmes E. Double-blind trial of 2-dimethylaminoethanol in Alzheimer's disease. Am J Psychiatry 1981;138:970-2.
- Ferris SH, Sathananthan G, Gershon S, et al. Senile dementia: treatment with deanol. J Am Geriatr Soc 1977;25:241-4.
- Cherkin A, Exkardt MJ. Effects of dimethylaminoethanol upon life-span and behavior of aged Japanese quail. J Gerontol 1977;32:38-45.
- Stenback F, Weisburger JH, Williams GM. Effect of lifetime administration of dimethylaminoethanol on longevity, aging changes, and cryptogenic neoplasms in C3H mice. Mech Ageing Dev 1988;42:129-38.
- Haug BA, Holzgraefe M. Orofacial and respiratory tardive dyskinesia: potential side effects of 2-dimethylaminoethanol (deanol)? Eur Neurol 1991;31:423-5.
- Casey DE. Mood alterations during deanol therapy. Psychopharmacology (Berl) 1979;62:187-91.
- Sergio W. Use of DMAE (2-dimethylaminoethanol) in the induction of lucid dreams. Med Hypotheses 1988;26:255-7.
- McGrath JJ, Soares KVS. Cholinergic medication for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev 2000;(2):CD000207.
- Soares KV, McGrath JJ. The treatment of tardive dyskinesia- a systematic review and meta-analysis. Schizophr Res 1999;39:1-16; discussion 17-18.
- Osol A, Hoover JE, eds. Remington's Pharmaceutical Science, 15th ed. Easton, PA: Mack Publishing Company, 1975.
- Uhoda I, Faska N, Robert C, et al. Split face study on the cutaneous tensile effect of 2-dimethylaminoethanol (deanol) gel. Skin Res Technol 2002;8:164-7.
- Coleman N, Dexheimer P, DiMascio A, et al. Deanol in the treatment of hyperkinetic children. Psychosomatics 1976;17(2):68-72.
- Krug O, Guddat S, Görgens C, Piper T, Möller T, Thevis M. Determination of urinary deanol-N-oxide excretion profiles after ingestion of nutritional supplements containing deanol. Drug Test Anal 2023.